Harel Insurance Investments & Financial Services’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,936	Closed	-$720K	–	573
2019 Q3	$720K	Hold	50,936	–	–	0.05%	82
2019 Q2	$1.79M	Sell	50,936 -3,687	-7%	-$200K	0.1%	67
2019 Q1	$3.06M	Sell	54,623 -22	-0%	-$1.19K	0.18%	61
2018 Q4	$2.62M	Hold	54,645	–	–	0.16%	65
2018 Q3	$3.97M	Hold	54,645	–	–	0.2%	63
2018 Q2	$4.51M	Hold	54,645	–	–	0.24%	58
2018 Q1	$5.74M	Hold	54,645	–	–	0.32%	54
2017 Q4	$7M	Buy	+54,645	New	+$6.72M	0.44%	44

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Harel Insurance Investments & Financial Services's VBIV Position: Q4 2019 in Review

Harel Insurance Investments & Financial Services sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2019, closing a stake of 50,936 shares — an estimated $720K sold.

Harel Insurance Investments & Financial Services first reported a position in VBIV in Q4 2017 and held it in 8 quarters. The position peaked at $7M in Q4 2017. 75 funds tracked by Wall St. Rank hold VBIV as of Q4 2019.

Harel Insurance Investments & Financial Services reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2019 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 50,936 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2019, an estimated $720K.
Harel Insurance Investments & Financial Services first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 8 quarters.
Harel Insurance Investments & Financial Services's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $7M in Q4 2017.
75 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2019.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2019, filed 23 Jan 2020.